Conversion and somatic symptom disorders

References

Key articles

Nowak DA, Fink GR. Psychogenic movement disorders: aetiology, phenomenology, neuroanatomical correlates and therapeutic approaches. Neuroimage. 2009 Sep;47(3):1015-25. Abstract

Baslet G. Psychogenic non-epileptic seizures: a model of their pathogenic mechanism. Seizure. 2011 Jan;20(1):1-13.Full text  Abstract

Reuber M. The etiology of psychogenic non-epileptic seizures: toward a biopsychosocial model. Neurol Clin. 2009 Nov;27(4):909-24. Abstract

Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 2008 Jun;37(6):339-52. Abstract

Kleinstauber M, Witthöft M, Hiller W. Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis. Clin Psychol Rev. 2011 Feb;31(1):146-60. Abstract

Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007 Dec;69(9):881-8. Abstract

Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet. 2007 Mar 17;369(9565):946-55. Abstract

Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med. 2007 Dec;69(9):889-900. Abstract

Reference articles

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., (DSM-5). Washington, DC: American Psychiatric Publishing; 2013.

2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV, 4th ed. Washington, DC: American Psychiatric Association; 1994.

3. Espay AJ, Aybek S, Carson A, et al. Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders. JAMA Neurol. 2018 Sep 1;75(9):1132-41.Full text  Abstract

4. Stone J, Zeman A, Sharpe M. Functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry. 2002 Sep;73(3):241-5.Full text  Abstract

5. Binzer M, Andersen PM, Kullgren G. Clinical characteristics of patients with motor disability due to conversion disorder: a prospective control group study. J Neurol Neurosurg Psychiatry. 1997 Jul;63(1):83-8.Full text  Abstract

6. Ford CV, Folks DG. Conversion disorders: an overview. Psychosomatics. 1985 May;26(5):371-4, 380-3. Abstract

7. Lazare A. Current concepts in psychiatry: conversion symptoms. N Engl J Med. 1981 Sep 24;305(13):745-8. Abstract

8. McKenzie PS, Oto M, Graham CD, et al. Do patients whose psychogenic non-epileptic seizures resolve, 'replace' them with other medically unexplained symptoms? Medically unexplained symptoms arising after a diagnosis of psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry. 2011 Sep;82(9):967-9. Abstract

9. Barsky AJ, Peekna HM, Borus JF. Somatic symptom reporting in women and men. J Gen Intern Med. 2001 Apr;16(4):266-75.Full text  Abstract

10. Tomasson K, Kent D, Coryell W. Somatization and conversion disorders: comorbidity and demographics at presentation. Acta Psychiatr Scand. 1991 Sep;84(3):288-93. Abstract

11. Guz H, Doganay Z, Ozkan A, et al. Conversion and somatization disorders: dissociative symptoms and other characteristics. J Psychosom Res. 2004 Mar;56(3):287-91. Abstract

12. Akagi J, House A. The epidemiology of hysterical conversion. In: Halligan PW, Bass CM, Marshall JC, eds. Contemporary approaches to the study of hysteria. Oxford, UK: Oxford University Press; 2001:73-87.

13. Carson AJ, Ringbauer B, Stone J, et al. Do medically unexplained symptoms matter? A prospective cohort study of 300 new referrals to neurology outpatient clinics. J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):207-10.Full text  Abstract

14. Factor SA, Podskalny GD, Molho ES. Psychogenic movement disorders: frequency, clinical profile, and characteristics. J Neurol Neurosurg Psychiatry. 1995 Oct;59(4):406-12.Full text  Abstract

15. Benbadis SR, Allen Hauser W. An estimate of the prevalence of psychogenic non-epileptic seizures. Seizure. 2000 Jun;9(4):280-1. Abstract

16. Krumholz A, Ting T. Coexisting epilepsy and nonepileptic seizures. In: Kaplan PW, Fisher RS, eds. Imitators of epilepsy. New York, NY: Demos Medical Publishing; 2005:261-76.

17. Kozlowska K, Nunn KP, Rose D, et al. Conversion disorder in Australian pediatric practice. J Am Acad Child Adolesc Psychiatry. 2007 Jan;46(1):68-75. Abstract

18. Stone J, Smyth R, Carson A, et al. Systematic review of misdiagnosis of conversion symptoms and "hysteria". BMJ. 2005 Oct 29;331(7523):989.Full text  Abstract

19. Stonnington CM, Locke DE, Hsu CH, et al. Somatization is associated with deficits in affective theory of mind. J Psychosom Res. 2013 Jun;74(6):479-85. Abstract

20. Katon W, Kleinman A, Rosen G. Depression and somatization: a review: part I. Am J Med. 1982 Jan;72(1):127-35. Abstract

21. Noyes R Jr, Holt CS, Kathol RG. Somatization: diagnosis and management. Arch Fam Med. 1995 Sep;4(9):790-5. Abstract

22. Brown RJ. The cognitive psychology of dissociative states. Cogn Neuropsychiatry. 2002 Aug;7(3):221-35. Abstract

23. Brown RJ, Cardena E, Nijenhuis E, et al. Should conversion disorder be reclassified as a dissociative disorder in DSM V? Psychosomatics. 2007 Sep-Oct;48(5):369-78. Abstract

24. Nowak DA, Fink GR. Psychogenic movement disorders: aetiology, phenomenology, neuroanatomical correlates and therapeutic approaches. Neuroimage. 2009 Sep;47(3):1015-25. Abstract

25. Baslet G. Psychogenic non-epileptic seizures: a model of their pathogenic mechanism. Seizure. 2011 Jan;20(1):1-13.Full text  Abstract

26. Black DN, Seritan AL, Taber KH, et al. Conversion hysteria: lessons from functional imaging. J Neuropsychiatry Clin Neurosci. 2004 Summer;16(3):245-51. Abstract

27. Voon V, Brezing C, Gallea C, et al. Emotional stimuli and motor conversion disorder. Brain. 2010 May;133(Pt 5):1526-36. Abstract

28. van der Kruijs SJ, Bodde NM, Vaessen MJ, et al. Functional connectivity of dissociation in patients with psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):239-47.Full text  Abstract

29. Cojan Y, Waber L, Carruzzo A, et al. Motor inhibition in hysterical conversion paralysis. Neuroimage. 2009 Sep;47(3):1026-37. Abstract

30. Ejareh Dar M, Kanaan RA. Uncovering the etiology of conversion disorder: insights from functional neuroimaging. Neuropsychiatr Dis Treat. 2016 Jan 13;12:143-53.Full text  Abstract

31. Voon V, Gallea C, Hattori N, et al. The involuntary nature of conversion disorder. Neurology. 2010 Jan 19;74(3):223-8. Abstract

32. Simeon D, Knutelska M, Yehuda R, et al. Hypothalamic-pituitary-adrenal axis function in dissociative disorders, post-traumatic stress disorder, and healthy volunteers. Biol Psychiatry. 2007 Apr 15;61(8):966-73.Full text  Abstract

33. Reuber M. The etiology of psychogenic non-epileptic seizures: toward a biopsychosocial model. Neurol Clin. 2009 Nov;27(4):909-24. Abstract

34. Geisser ME, Strader Donnell C, Petzke F, et al. Comorbid somatic symptoms and functional status in patients with fibromyalgia and chronic fatigue syndrome: sensory amplification as a common mechanism. Psychosomatics. 2008 May-Jun;49(3):235-42. Abstract

35. Browning M, Fletcher P, Sharpe M. Can neuroimaging help us to understand and classify somatoform disorders? A systematic and critical review. Psychosom Med. 2011 Feb-Mar;73(2):173-84.Full text  Abstract

36. Dimsdale JE, Dantzer R. A biological substrate for somatoform disorders: importance of pathophysiology. Psychosom Med. 2007 Dec;69(9):850-4. Abstract

37. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun. 2007 Feb;21(2):153-60.Full text  Abstract

38. Yunus MB. Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum. 2008 Jun;37(6):339-52. Abstract

39. Fiszman A, Alves-Leon SV, Nunes RG, et al. Traumatic events and posttraumatic stress disorder in patients with psychogenic nonepileptic seizures: a critical review. Epilepsy Behav. 2004 Dec;5(6):818-25. Abstract

40. Roelofs K, Keijsers GP, Hooqduin KA, et al. Childhood abuse in patients with conversion disorder. Am J Psychiatry. 2004 Dec;5(6):818-25. Abstract

41. Spitzer C, Barnow S, Gau K, et al. Childhood maltreatment in patients with somatization disorder. Aust N Z J Psychiatry. 2008 Apr;42(4):335-41. Abstract

42. Schulte IE, Petermann F. Familial risk factors for the development of somatoform symptoms and disorders in children and adolescents: a systematic review. Child Psychiatry Hum Dev. 2011 Oct;42(5):569-83. Abstract

43. Edwards VJ, Holden GW, Felitti VJ, et al. Relationship between multiple forms of childhood maltreatment and adult mental health in community respondents: results from the adverse childhood experiences study. Am J Psychiatry. 2003 Aug;160(8):1453-60.Full text  Abstract

44. Choi J, Jeong B, Rohan ML, et al. Preliminary evidence for white matter tract abnormalities in young adults exposed to parental verbal abuse. Biol Psychiatry. 2009 Feb 1;65(3):227-34. Abstract

45. De Gucht V, Heiser W. Alexithymia and somatisation: quantitative review of the literature. J Psychosom Res. 2003 May;54(5):425-34. Abstract

46. Mattila AK, Kronholm E, Jula A, et al. Alexithymia and somatization in general population. Psychosom Med. 2008 Jul;70(6):716-22. Abstract

47. De Gucht V. Stability of neuroticism and alexithymia in somatization. Compr Psychiatry. 2003 Nov-Dec;44(6):466-71. Abstract

48. Joint Working Group of the Royal College of General Practitioners and the Royal College of Psychiatrists. The management of patients with physical and psychological problems in primary care: a practical guide. Jan 2009 [internet publication].Full text

49. Agarwal V, Srivastava C, Sitholey P. Clinical Practice Guidelines for the management of Somatoform Disorders in Children and Adolescents. Indian J Psychiatry. 2019 Jan;61(suppl 2):241-6.Full text  Abstract

50. van Bokhoven MA, Koch H, van der Weijden T, et al. The effect of watchful waiting compared to immediate test ordering instructions on general practitioners' blood test ordering behaviour for patients with unexplained complaints; a randomized clinical trial (ISRCTN55755886). Implement Sci. 2012 Apr 4;7:29Full text  Abstract

51. Hallet M, Cloninger CR, Fahn S, et al. Psychogenic movement disorders: neurology and neuropsychiatry. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.

52. Hurwitz TA. Somatization and conversion disorder. Can J Psychiatry. 2004 Mar;49(3):172-8. Abstract

53. Burke MJ. "It's all in your head" - medicine's silent epidemic. JAMA Neurol. 2019;76(12):1417-8. Abstract

54. Abubakr A, Kablinger A, Caldito G. Psychogenic seizures: clinical features and psychological analysis. Epilepsy Behav. 2003 Jun;4(3):241-5. Abstract

55. Tolchin B, Martino S, Hirsch LJ. Treatment of patients with psychogenic nonepileptic attacks. JAMA. 2019 May 28;321(20):1967-8. Abstract

56. Kroenke K, Spitzer RL, Williams JB, et al. The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):345-59. Abstract

57. Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto Alexithymia Scale - I: item selection and cross-validation of the factor structure. J Psychosom Res. 1994 Jan;38(1):23-32. Abstract

58. Bagby RM, Taylor GJ, Parker JD. The twenty-item Toronto Alexithymia Scale - II: convergent, discriminant, and concurrent validity. J Psychosom Res. 1994 Jan;38(1):33-40. Abstract

59. Taylor GJ, Bagby RM, Parker JD. The 20-item Toronto Alexithymia Scale - IV: reliability and factorial validity in different languages and cultures. J Psychosom Res. 2003 Sep;55(3):277-83. Abstract

60. Lane RD, Quinlan DM, Schwartz GE, et al. The Levels of Emotional Awareness Scale: a cognitive-developmental measure of emotion. J Pers Assess. 1990;55(1-2):124-34. Abstract

61. Binder LM, Campbell KA. Medically unexplained symptoms and neuropsychological assessment. J Clin Exp Neuropsychol. 2004 May;26(3):369-92. Abstract

62. Drane DL, Williamson DJ, Stroup ES, et al. Cognitive impairment is not equal in patients with epileptic and psychogenic nonepileptic seizures. Epilepsia. 2006 Nov;47(11):1879-86.Full text  Abstract

63. Locke DE, Berry DT, Fakhoury TA, et al. Relationship of indicators of neuropathology, psychopathology, and effort to neuropsychological results in patients with epilepsy or psychogenic non-epileptic seizures. J Clin Exp Neuropsychol. 2006 Apr;28(3):325-40. Abstract

64. Hathaway SR, McKinley. MMPI-2: Minnesota Multiphasic Personality Inventory-2: manual for administration and scoring. Minneapolis, MN: University of Minnesota Press; 1989.

65. Morey LC. Personality assessment inventory. Odessa, FL: Psychological Assessment Resources; 1991.

66. Millon T. Millon Clinical Multiaxial Inventory-II: manual for the MCM-II. Minneapolis, MN: National Computer Systems; 1994.

67. Cragar DE, Schmitt FA, Berry DT, et al. A comparison of MMPI-2 decision rules in the diagnosis of nonepileptic seizures. J Clin Exp Neuropsychol. 2003 Sep;25(6):793-804. Abstract

68. Schuster JP, Mouchabac S, LeStrat Y, et al. Hysterical mutism [in French]. Encephale. 2011 Oct;37(5):339-44. Abstract

69. Salkovskis PM, Rimes KA, Warwick HM, et al. The health anxiety inventory: development and validation of scales for the measurement of health anxiety and hypochondriasis. Psychol Med. 2002 Jul;32(5):843-53. Abstract

70. van der Feltz-Cornelis CM, Hoedeman R, Keuter EJ, et al. Presentation of the Multidisciplinary Guideline Medically Unexplained Physical Symptoms (MUPS) and Somatoform Disorder in the Netherlands: disease management according to risk profiles. J Psychosom Res. 2012 Feb;72(2):168-9.Full text  Abstract

71. Stewart M, Brown JB, Weston WW, et al. Patient-centered medicine: transforming the clinical method. Thousand Oaks, CA: Sage; 1995.

72. Drane DL, LaRoche SM, Ganesh GA, et al. A standardized diagnostic approach and ongoing feedback improves outcome in psychogenic nonepileptic seizures. Epilepsy Behav. 2016 Jan 1;54:34-9.Full text  Abstract

73. Goldstein LH, Chalder T, Chigwedere C, et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology. 2010 Jul;51(7):1169-76. Abstract

74. LaFrance WC Jr, Miller IW, Ryan CE, et al. Behavioral therapy for psychogenic nonepileptic seizures. Epilepsy Behav. 2009 Apr;14(4):591-6. Abstract

75. van Dessel N, den Boeft M, van der Wouden JC, et al. Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev. 2014 Nov 1;(11):CD011142.Full text  Abstract

76. LaFrance WC Jr, Baird GL, Barry JJ, et al; NES Treatment Trial (NEST-T) Consortium. Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial. JAMA Psychiatry. 2014 Sep;71(9):997-1005.Full text  Abstract

77. Sharpe M, Walker J, Williams C, et al. Guided self-help for functional (psychogenic) symptoms: a randomized controlled efficacy trial. Neurology. 2011 Aug 9;77(6):564-72.Full text  Abstract

78. Hedman E, Axelsson E, Görling A, et al. Internet-delivered exposure-based cognitive-behavioural therapy and behavioural stress management for severe health anxiety: randomised controlled trial. Br J Psychiatry. 2014 Oct;205(4):307-14.Full text  Abstract

79. Zonneveld LN, van Rood YR, Timman R, et al. Effective group training for patients with unexplained physical symptoms: a randomized controlled trial with a non-randomized one-year follow-up. PLoS One. 2012 Aug 7;7(8):e42629 [corrected in: PLoS One. 2013;8].Full text  Abstract

80. Fjorback LO. Mindfulness and bodily distress. Dan Med J. 2012 Nov;59(11):B4547.Full text  Abstract

81. Fjorback LO, Arendt M, Ornbøl E, et al. Mindfulness therapy for somatization disorder and functional somatic syndromes: randomized trial with one-year follow-up. J Psychosom Res. 2013 Jan;74(1):31-40. Abstract

82. Abbass A, Kisely S, Kroenke K. Short-term psychodynamic psychotherapy for somatic disorders: systematic review and meta-analysis of clinical trials. Psychother Psychosom. 2009;78(5):265-74. Abstract

83. Erceg-Hurn DM. Psychodynamic therapy for somatic disorder meta-analysis raises more questions than answers. Psychother Psychosom. 2011 Mar 9;80(3):182-3. Abstract

84. Abbass AA, Kisely SR, Town JM, et al. Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database Syst Rev. 2014 Jul 1;(7):CD004687.Full text  Abstract

85. Morriss RK, Dowrick C, Salmon P, et al. Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. Br J Psychiatry. 2007 Dec;191:536-42.Full text  Abstract

86. Mayor R, Howlett S, Grünewald R, et al. Long-term outcome of brief augmented psychodynamic interpersonal therapy for psychogenic nonepileptic seizures: seizure control and health care utilization. Epilepsia. 2010 Jul;51(7):1169-76. Abstract

87. Sattel H, Lahmann C, Gundel H, et al. Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial. Br J Psychiatry. 2012 Jan;200(1):60-7. Abstract

88. Kleinstauber M, Witthöft M, Hiller W. Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis. Clin Psychol Rev. 2011 Feb;31(1):146-60. Abstract

89. Martlew J, Pulman J, Marson AG. Psychological and behavioural treatments for adults with non-epileptic attack disorder. Cochrane Database Syst Rev. 2014 Feb 11;(2):CD006370.Full text  Abstract

90. Kisely SR, Campbell LA, Yelland MJ, et al. Psychological interventions for symptomatic management of non-specific chest pain in patients with normal coronary anatomy. Cochrane Database Syst Rev. 2015 Jun 30;2015(6):CD004101.Full text  Abstract

91. Wortman MS, Lucassen PL, van Ravesteijn HJ, et al. Brief multimodal psychosomatic therapy in patients with medically unexplained symptoms: feasibility and treatment effects. Fam Pract. 2016 Aug;33(4):346-53. Abstract

92. Schade N, Torres P, Beyebach M. Cost-efficiency of a brief family intervention for somatoform patients in primary care. Fam Syst Health. 2011 Sep;29(3):197-205. Abstract

93. Griffith JL, Polles A, Griffith ME. Pseudoseizures, families, and unspeakable dilemmas. Psychosomatics. 1998 Mar-Apr;39(2):144-53. Abstract

94. Wagner AW, Rizvi SL, Harned MS. Applications of dialectical behavior therapy to the treatment of complex trauma-related problems: when one case formulation does not fit all. J Trauma Stress. 2007 Aug;20(4):391-400. Abstract

95. Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007 Dec;69(9):881-8. Abstract

96. LaFrance WC Jr, Barry JJ. Update on treatments of psychological nonepileptic seizures. Epilepsy Behav. 2005 Nov;7(3):364-74. Abstract

97. Nielsen G, Buszewicz M, Stevenson F, et al. Randomised feasibility study of physiotherapy for patients with functional motor symptoms. J Neurol Neurosurg Psychiatry. 2017 Jun;88(6):484-90.Full text  Abstract

98. Nielsen G, Stone J, Matthews A, et al. Physiotherapy for functional motor disorders: a consensus recommendation. J Neurol Neurosurg Psychiatry. 2015 Oct;86(10):1113-9.Full text  Abstract

99. Kleinstäuber M, Witthöft M, Steffanowski A, et al. Pharmacological interventions for somatoform disorders in adults. Cochrane Database Syst Rev. 2014 Nov 7;(11):CD010628.Full text  Abstract

100. Reuber M, Burness C, Howlett S, et al. Tailored psychotherapy for patients with functional neurological symptoms: a pilot study. J Psychosom Res. 2007 Dec;63(6):625-32. Abstract

101. Prigatano GP, Stonnington CM, Fisher RS. Psychological factors in the genesis and management of nonepileptic seizures: clinical observations. Epilepsy Behav. 2002 Aug;3(4):343-39. Abstract

102. Drake ME Jr, Pakalnis A, Phillips BB. Neuropsychological and psychiatric correlates of intractable pseudoseizures. Seizure. 1992 Mar;1(1):11-3. Abstract

103. Marazziti D, Dell'Osso B. Effectiveness of risperidone in psychogenic stiff neck. CNS Spectr. 2005 Jun;10(6):443-4. Abstract

104. Persinger MA. Seizure suggestibility may not be an exclusive differential indicator between psychogenic and partial complex seizures: the presence of a third factor. Seizure. 1994 Sep;3(3):215-9. Abstract

105. Dabholkar PD. Use of ECT in hysterical catatonia: a case report and discussion. Br J Psychiatry. 1988 Aug;153:246-7. Abstract

106. Daniel WF, Crovitz HF. ECT-induced alteration of psychogenic amnesia. Acta Psychiatr Scand. 1986 Sep;74(3):302-3. Abstract

107. Edwards JG. Electroconvulsive therapy in the treatment of bizarre psychogenic movements. Br J Psychiatry. 1969 Sep;115(526):1065-7. Abstract

108. Chastan N, Parain D, Verin E, et al. Psychogenic aphonia: spectacular recovery after motor cortex transcranial magnetic stimulation. J Neurol Neurosurg Psychiatry. 2009 Jan;80(1):94. Abstract

109. Geraldes R, Coelho M, Rosa MM, et al. Abnormal transcranial magnetic stimulation in a patient with presumed psychogenic paralysis. J Neurol Neurosurg Psychiatry. 2008 Dec;79(12):1412-3. Abstract

110. Schonfeldt-Lecuona C, Connemann BJ, Spitzer M, et al. Transcranial magnetic stimulation in the reversal of motor conversion disorder. Psychother Psychosom. 2003 Sep-Oct;72(5):286-8. Abstract

111. Smith GR Jr, Monson RA, Ray DC. Psychiatric consultation in somatization disorder: a randomized controlled study. N Engl J Med. 1986 May 29;314(22):1407-13. Abstract

112. Hoedeman R, Blankenstein AH, van der Feltz-Cornelis CM, et al. Consultation letters for medically unexplained physical symptoms in primary care. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006524. Abstract

113. Henningsen P. Management of somatic symptom disorder. Dialogues Clin Neurosci. 2018 Mar;20(1):23-31. Abstract

114. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet. 2007 Mar 17;369(9565):946-55. Abstract

115. Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med. 2007 Dec;69(9):889-900. Abstract

116. Bernardy K, Füber N, Köllner V, et al. Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome: a systematic review and metaanalysis of randomized controlled trials. J Rheumatol. 2010 Oct;37(10):1991-2005. Abstract

117. Allen LA, Woolfolk RL, Escobar JI, et al. Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med. 2006 Jul 24;166(14):1512-8.Full text  Abstract

118. Poole NA, Wuerz A, Agrawal N. Abreaction for conversion disorder: systematic review with meta-analysis. Br J Psychiatry. 2010 Aug;197(2):91-5.Full text  Abstract

119. Rosen AC, Ramkumar M, Nguyen T, et al. Noninvasive transcranial brain stimulation and pain. Curr Pain Headache Rep. 2009 Feb;13(1):12-7.Full text  Abstract

120. Grisaru N, Amir M, Cohen H, et al. Effect of transcranial magnetic stimulation in posttraumatic stress disorder: a preliminary study. Biol Psychiatry. 1998 Jul 1;44(1):52-5. Abstract

121. Hafeiz HB. Hysterical conversion: a prognostic study. Br J Psychiatry. 1980 Jun;136:548-51. Abstract

122. Robins LN, Regier DA, eds. Psychiatric disorders in America. New York, NY: Free Press; 1991:220-57.

123. Bass CM, Murphy MR. Somatization disorder: critique of the concept and suggestions for future research. In: Bass CM, ed. Somatization: physical symptoms and psychological illness. Oxford, UK: Blackwell; 1990.

124. Zwaigenbaum L, Szatmari P, Boyle MH, et al. Highly somatizing young adolescents and the risk of depression. Pediatrics. 1999 Jun;103(6 Pt 1):1203-9. Abstract

125. Williams C, Smith S, Sharpe M, et al. Overcoming functional neurological symptoms: a five areas approach. Boca Raton, FL: CRC Press; 2011.

Use of this content is subject to our disclaimer